Abstract
Inherited bone marrow failure syndromes (IBMFS) present chronic bone marrow failures, a familial incidence and high risk of malignancy.
Objective: we describe our experience with patients with IBMFS. Since 02/73 to 02/05, 60 patients (pts) with IBMSF were diagnosed.
. | Fanconi’s Anemia . | Blackfand-Diamond . | TAR-Shwachman-Diamond-Dyskeratosis Congenita . | Amegakaryocytic Thrombocytopenia.- Kostmann’s S. . | Familial AA-Pearson’s S . |
---|---|---|---|---|---|
N Pts | 26 | 17 | 6 – 2 – 2 | 2 – 2 | 2 – 1 |
Median age at diagnosis | 7.1 y | 3 m | 3m – 4 m – 6.4 y | 2 m – 1.8 m | 4 y – 3 y |
First hematologic sign | Pancytopenia | Anemia | Thrombocytop. – Neutrop. – Pancytop. | Thrombocytop. – Neutrop. | Pancytop. – Anemia |
Bone Marrow | Aplastic | Erythroid Aplasia | Megakar. Aplasia – Myeloid arrest– Aplastic | Megakar. Aplasia– Myeloid arrest | Aplastic – Vacuolated myeloid |
Physical Abnorm.(%) | 88 | 47 | 100 – 50– 100 | 50 – 0 | 0 – 0 |
Aplastic Anemia (%) | 100 | 0 | 0 – 0 – 100 | 50 – 0 | 100 – 100 |
Leukemia / MDS (%) | 11.5 | 0 | 0 – 0 – 0 | 0 – 0 | 0 – 0 |
Mortality(%) | 62 | 0 | 17 – 50 – 0 | 50 – 50 | 50 – 0 |
. | Fanconi’s Anemia . | Blackfand-Diamond . | TAR-Shwachman-Diamond-Dyskeratosis Congenita . | Amegakaryocytic Thrombocytopenia.- Kostmann’s S. . | Familial AA-Pearson’s S . |
---|---|---|---|---|---|
N Pts | 26 | 17 | 6 – 2 – 2 | 2 – 2 | 2 – 1 |
Median age at diagnosis | 7.1 y | 3 m | 3m – 4 m – 6.4 y | 2 m – 1.8 m | 4 y – 3 y |
First hematologic sign | Pancytopenia | Anemia | Thrombocytop. – Neutrop. – Pancytop. | Thrombocytop. – Neutrop. | Pancytop. – Anemia |
Bone Marrow | Aplastic | Erythroid Aplasia | Megakar. Aplasia – Myeloid arrest– Aplastic | Megakar. Aplasia– Myeloid arrest | Aplastic – Vacuolated myeloid |
Physical Abnorm.(%) | 88 | 47 | 100 – 50– 100 | 50 – 0 | 0 – 0 |
Aplastic Anemia (%) | 100 | 0 | 0 – 0 – 100 | 50 – 0 | 100 – 100 |
Leukemia / MDS (%) | 11.5 | 0 | 0 – 0 – 0 | 0 – 0 | 0 – 0 |
Mortality(%) | 62 | 0 | 17 – 50 – 0 | 50 – 50 | 50 – 0 |
Conclusion: 68 % pts. presented with associated physical abnormalities, 53 % began the symptoms with bone marrow aplasia. With a median follow up: 16. 3 years (r: 1y – 32 y), 39 (65%) pts are alive (9 pts. post bone marrow transplantation) and 3 pts with Fanconi’s Anemia developed refractory Acute Myeloblastic Leukemia.
Author notes
Corresponding author
2005, The American Society of Hematology
2005
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal